SCHEMBL30219568

SCHEMBL30219568

Nc1ncc2ccn(-c3cc(Br)ccc3F)c2n1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAP3K14 Q99558 13/20 0.49
▸ MAPKAPK2 P49137 1/20 0.44
▸ CDC7 O00311 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ ROCK1 Q13464 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ TRAP1 Q12931 1/20 0.38
▸ PTK2 Q05397 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ LCK P06239 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ DHFR P00374 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28986262 1.00 MAP3K14 (0.49) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL30219561 0.84 MAP3K14 (0.50) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL28986302 0.84 MAP3K14 (0.49) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL30219567 0.84 MAP3K14 (0.50) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL28986271 0.84 MAP3K14 (0.50) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL28986265 0.84 MAP3K14 (0.50) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL30219605 0.81 MAP3K14 (0.53) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL28986228 0.81 MAP3K14 (0.53) MAP3K14MAPKAPK2CDC7CDK2ROCK1
SCHEMBL28986263 0.78 MAPKAPK2 (0.56) MAP3K14MAPKAPK2LCKKITSRC
SCHEMBL28986246 0.77 MAPKAPK2 (0.57) MAP3K14MAPKAPK2CDC7CDK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109810110-B Compound with 2-aminopyrimidine structure, preparation method and application thereof 中国科学院上海药物研究所 2023-01-24 — — CN disclosed
Send feedback